Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,144 public trials 2,036 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, not recruiting

A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma

NCT04133636

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University Of California San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 47 locations
View Trial Details
Active, not recruiting

A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

NCT05784441

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • University of Iowa Hospital Iowa City, Iowa, United States
  • University of Kentucky Lexington, Kentucky, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Rutgers University New Brunswick, New Jersey, United States
View all 15 locations
View Trial Details
Active, not recruiting

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

NCT07030517

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • M S Ramaiah Medical College and Hospital Bangalore, India
  • St. Johns Medical College And Hospital Bengaluru, India
  • Post Graduate Institute of Medical Education And Research PGIMER Chandigarh, India
  • Bhagwan Mahaveer Cancer Hospital & Research Centre Jaipur, India
View Trial Details
Active, not recruiting

A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

NCT06470438

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Sun Yat Sen University Cancer Center Guangzhou, China
  • The First Affiliated Hospital Zhejiang University College of Medicine Hangzhou, China
  • Fudan University Shanghai Cancer Center Shanghai, China
View all 19 locations
View Trial Details
Active, not recruiting

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

NCT04802590

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • A.Z. Sint Jan AV Bruges, Belgium
  • Universite Libre de Bruxelles - Hopital ERASME Brussels, Belgium
  • Hopital Jolimont Haine-Saint-Paul, Belgium
  • CHU de Liege Liège, Belgium
View all 45 locations
View Trial Details
Active, not recruiting

A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

NCT05512390

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +21 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 247752 Tucson, Arizona, United States
  • Sylvester Comprehensive Cancer Center - University of Miami /ID# 247232 Miami, Florida, United States
  • Allina Health System /ID# 251782 Minneapolis, Minnesota, United States
  • University of Nebraska Medical Center /ID# 246715 Omaha, Nebraska, United States
View all 20 locations
View Trial Details
Active, not recruiting

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

NCT03737981

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 857 locations
View Trial Details
Active, not recruiting

A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma

NCT04108195

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • University of California San Francisco San Francisco, California, United States
  • The Blavatnik Family Chelsea Medical Center at Mount Sinai New York, United States
View all 24 locations
View Trial Details
Active, not recruiting

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

NCT05963074

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • The Oncology Institute Clinical Research Cerritos, California, United States
  • Cancer and Blood Specialty Clinic Los Alamitos, California, United States
  • SLO Oncology and Hematology Health Center San Luis Obispo, California, United States
  • Providence Medical Foundation Santa Rosa, California, United States
View all 74 locations
View Trial Details
Active, not recruiting

Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00602641

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Sparks Regional Medical Center Fort Smith, Arkansas, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 391 locations
View Trial Details

Related conditions